Top

International Ophthalmology

Published in:

01-09-2020 | Original Paper

Does systemic inflammation play a role in patients with pterygium?

Authors: Deniz Kilic, Soner Guven

Published in: International Ophthalmology | Issue 9/2020

Abstract

Purpose

To compare parameters of systemic inflammation and serum lipid levels in patients with pterygium versus healthy individuals.

Methods

Thirty-five patients with pterygium and 30 healthy individuals were enrolled as two respective groups in a retrospective study. The participants’ complete blood count (CBC) parameters and levels of serum total cholesterol, low-density lipoprotein, high-density lipoprotein (HDL), and triglycerides (TG) were obtained from digital records and compared. Their neutrophil/lymphocyte, platelet/lymphocyte, and monocyte/HDL ratios were calculated and compared as well. As secondary outcomes, longitudinal length (LL), basal length (BL), and total area (TA) of pterygium among the patients were quantitatively measured by using ImageJ software. Correlations between serum parameters and pterygium measurements were analyzed.

Results

Although between-group differences in CBC parameters and the ratios were not statistically significant, HDL levels were significantly lower (p = 0.014) and TG levels significantly higher (p = 0.031) among patients with pterygium than among the controls. A positive correlation was detected between the patient’s age and the pterygium’s BL (p = 0.002, r = 0.516), LL (p = 0.00, r = 0.547), and TA (p = 0.00, r = 0.515). Neutrophil levels negatively correlated with LL (p = 0.025, β = − 0.308) and TA (p = 0.002, β = − 0.420).

Conclusion

Local instead of systemic inflammation should be considered in the management of pterygium. Besides, decreased HDL levels may indicate systemic oxidative stress in patients with the condition.

Dinc E, Dursun O, Yilmaz B et al (2018) Expression of prostaglandin E2 receptor subtypes in human pterygium and normal conjunctiva: immunohistochemical study. Int Ophthalmol 38:1703–1708. https://doi.org/10.1007/s10792-017-0651-yPubMedCrossRef

Kilic R, Kurt A, Tad M, Tasdemir S (2017) Endocan overexpression in pterygium. Cornea 36:696–699. https://doi.org/10.1097/ICO.0000000000001183PubMedCrossRef

Koc M, Yavrum F, Uzel MM et al (2018) The effect of pterygium and pterygium surgery on corneal biomechanics. Semin Ophthalmol 33:449–453. https://doi.org/10.1080/08820538.2017.1297839PubMedCrossRef

Taylor H, West S, Munoz B et al (1992) The long-term effects of visible light on the eye. Arch Ophthalmol 110:99–104PubMedCrossRef

Moran DJ, Hollows F (1984) Pterygium and ultraviolet irradiation: a positive correlation. Br J Ophthalmol 68:343–346PubMedPubMedCentralCrossRef

Bautista-de Lucio VM, Lopez-Espinosa NL, Robles-Contreras A et al (2013) Overexpression of peroxiredoxin 2 in pterygium. A proteomic approach. Exp Eye Res 110:70–75. https://doi.org/10.1016/j.exer.2013.03.001PubMedCrossRef

Sano I, Kaidzu S, Tanito M et al (2013) 4-Hydroxyhexenal- and 4-hydroxynonenal-modified proteins in pterygia. Oxid Med Cell Longev 2013:602029. https://doi.org/10.1155/2013/602029PubMedPubMedCentralCrossRef

Sun N, Zhang H (2018) Pyroptosis in pterygium pathogenesis. Biosci Rep. https://doi.org/10.1042/BSR20180282PubMedPubMedCentralCrossRef

Pan Z, Cui J, Shan G et al (2019) Prevalence and risk factors for pterygium: a cross-sectional study in Han and Manchu ethnic populations in Hebei, China. BMJ Open 9:e025725. https://doi.org/10.1136/bmjopen-2018-025725PubMedPubMedCentralCrossRef

10.

Ozdin S, Sarisoy G, Boke O (2017) A comparison of the neutrophil-lymphocyte, platelet-lymphocyte and monocyte-lymphocyte ratios in schizophrenia and bipolar disorder patients—a retrospective file review. Nord J Psychiatry 71:509–512. https://doi.org/10.1080/08039488.2017.1340517PubMedCrossRef

11.

Ulu SM, Dogan M, Ahsen A et al (2013) Neutrophil-to-lymphocyte ratio as a quick and reliable predictive marker to diagnose the severity of diabetic retinopathy. Diabetes Technol Ther 15:942–947. https://doi.org/10.1089/dia.2013.0097PubMedCrossRef

12.

Yılmaz M, Kayançiçek H (2018) A new ınflammatory marker: elevated monocyte to HDL cholesterol ratio associated with smoking. J Clin Med. https://doi.org/10.3390/jcm7040076PubMedPubMedCentralCrossRef

13.

Ganjali S, Gotto AMJ, Ruscica M et al (2018) Monocyte-to-HDL-cholesterol ratio as a prognostic marker in cardiovascular diseases. J Cell Physiol 233:9237–9246. https://doi.org/10.1002/jcp.27028PubMedCrossRef

14.

Ozgonul C, Sertoglu E, Mumcuoglu T, Kucukevcilioglu M (2016) Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as novel biomarkers of primary open-angle glaucoma. J Glaucoma 25:e815–e820. https://doi.org/10.1097/IJG.0000000000000392PubMedCrossRef

15.

Polat O, Yavas GF, Inan S, Inan UU (2015) Neutrophil-to-lymphocyte ratio as a marker in patients with non-arteritic anterior ıschemic optic neuropathy. Balkan Med J 32:382–387. https://doi.org/10.5152/balkanmedj.2015.15689PubMedPubMedCentralCrossRef

16.

Karaca EE, Ozmen MC, Ekici F et al (2014) Neutrophil-to-lymphocyte ratio may predict progression in patients with keratoconus. Cornea 33:1168–1173. https://doi.org/10.1097/ICO.0000000000000260PubMedCrossRef

17.

Guven S, Kilic D (2020) Neutrophil to lymphocyte ratio (NLR) is a better tool rather than monocyte to high-density lipoprotein ratio (MHR) and platelet to lymphocyte ratio (PLR) in central retinal artery occlusions. Ocul Immunol Inflamm. https://doi.org/10.1080/09273948.2020.1712433PubMedCrossRef

18.

Schneider CA, Rasband WS, Eliceiri KW (2012) NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9:671–675PubMedPubMedCentralCrossRef

19.

Kim YJ, Yang HK, Lee YJ et al (2019) Efficacy of a new automated method for quantification of corneal neovascularisation. Br J Ophthalmol. https://doi.org/10.1136/bjophthalmol-2019-314711PubMedCrossRef

20.

Rong X, Cai Y, Li M et al (2019) Peripapillary retinal artery in first diagnosed and untreated normal tension glaucoma. BMC Ophthalmol 19:203. https://doi.org/10.1186/s12886-019-1211-1PubMedPubMedCentralCrossRef

21.

Song P, Chang X, Wang M, An L (2017) Variations of pterygium prevalence by age, gender and geographic characteristics in China: a systematic review and meta-analysis. PLoS ONE 12:e0174587. https://doi.org/10.1371/journal.pone.0174587PubMedPubMedCentralCrossRef

22.

Rezvan F, Khabazkhoob M, Hooshmand E et al (2018) Prevalence and risk factors of pterygium: a systematic review and meta-analysis. Surv Ophthalmol 63:719–735. https://doi.org/10.1016/j.survophthal.2018.03.001PubMedCrossRef

23.

Bradley JC, Yang W, Bradley RH et al (2010) The science of pterygia. Br J Ophthalmol 94:815–820. https://doi.org/10.1136/bjo.2008.151852PubMedCrossRef

24.

Kormanovski A, Parra F, Jarillo-Luna A et al (2014) Oxidant/antioxidant state in tissue of prymary and recurrent pterygium. BMC Ophthalmol 14:149. https://doi.org/10.1186/1471-2415-14-149PubMedPubMedCentralCrossRef

25.

Gharaee H, Shayegan MR, Khakzad MR et al (2014) The expression of vascular endothelial growth factor in pterygium tissue of atopic patients. Int Ophthalmol 34:1175–1181. https://doi.org/10.1007/s10792-013-9876-6PubMedCrossRef

26.

Chui J, Coroneo MT, Tat LT et al (2011) Ophthalmic pterygium: a stem cell disorder with premalignant features. Am J Pathol 178:817–827. https://doi.org/10.1016/j.ajpath.2010.10.037PubMedPubMedCentralCrossRef

27.

Ye J, Song YS, Kang SH et al (2004) Involvement of bone marrow-derived stem and progenitor cells in the pathogenesis of pterygium. Eye (Lond) 18:839–843. https://doi.org/10.1038/sj.eye.6701346CrossRef

28.

Lee JK, Song YS, Ha HS et al (2007) Endothelial progenitor cells in pterygium pathogenesis. Eye (Lond) 21:1186–1193. https://doi.org/10.1038/sj.eye.6702433CrossRef

29.

Ozcan Cetin EH, Cetin MS, Aras D et al (2016) Platelet to lymphocyte ratio as a prognostic marker of ın-hospital and long-term major adverse cardiovascular events in ST-segment elevation myocardial ınfarction. Angiology 67:336–345. https://doi.org/10.1177/0003319715591751PubMedCrossRef

30.

Wang Q, Ma J, Jiang Z, Ming L (2018) Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in acute pulmonary embolism: a systematic review and meta-analysis. Int Angiol 37:4–11. https://doi.org/10.23736/S0392-9590.17.03848-2PubMedCrossRef

31.

Li S, Cao W, Han J et al (2017) The diagnostic value of white blood cell, neutrophil, neutrophil-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio in patients with primary angle closure glaucoma. Oncotarget 8:68984–68995. https://doi.org/10.18632/oncotarget.16571PubMedPubMedCentralCrossRef

32.

Hammad M, Shehata OZ, Abdel-Latif SM, El-Din AMM (2018) Neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in Behcet’s disease: which and when to use? Clin Rheumatol 37:2811–2817. https://doi.org/10.1007/s10067-018-4194-zPubMedCrossRef

33.

Ozgonul C, Sertoglu E, Mumcuoglu T et al (2016) Prediction of pseudoexfoliation syndrome and pseudoexfoliation glaucoma by using neutrophil to lymphocyte ratio and platelet to lymphocyte ratio. Ocul Immunol Inflamm 24:665–670. https://doi.org/10.3109/09273948.2015.1063671PubMedCrossRef

34.

Kurtul BE, Kabatas EU, Ozates S (2019) The correlation of routine hematological indices with pterygium. Ther Adv Ophthalmol 11:2515841419848922. https://doi.org/10.1177/2515841419848922PubMedPubMedCentralCrossRef

35.

Ucakhan OO, Kanpolat A, Elgun S, Durak I (2009) The role of oxidative mechanisms in the etiopathogenesis of pterygium: a preliminary study. Ophthalmol J Int d’ophtalmologie Int J Ophthalmol Zeitschrift fur Augenheilkd 223:41–46. https://doi.org/10.1159/000167020CrossRef

36.

Klebe S, Callahan T, Power JHT (2014) Peroxiredoxin I and II in human eyes: cellular distribution and association with pterygium and DNA damage. J Histochem Cytochem 62:85–96. https://doi.org/10.1369/0022155413508409PubMedPubMedCentralCrossRef

37.

Kilic-Toprak E, Toprak I, Caliskan S et al (2019) Oxidative stress and genotoxicity in pterygium: a systemic ınvestigation. Eye Contact Lens 45:399–404. https://doi.org/10.1097/ICL.0000000000000620PubMedCrossRef

38.

Karlsson H, Kontush A, James RW (2015) Functionality of HDL: antioxidation and detoxifying effects. Handb Exp Pharmacol 224:207–228. https://doi.org/10.1007/978-3-319-09665-0_5PubMedCrossRef

39.

Brites F, Martin M, Guillas I, Kontush A (2017) Antioxidative activity of high-density lipoprotein (HDL): mechanistic insights into potential clinical benefit. BBA Clin 8:66–77. https://doi.org/10.1016/j.bbacli.2017.07.002PubMedPubMedCentralCrossRef

40.

Zablocka-Slowinska K, Placzkowska S, Skorska K et al (2019) Oxidative stress in lung cancer patients is associated with altered serum markers of lipid metabolism. PLoS ONE 14:e0215246. https://doi.org/10.1371/journal.pone.0215246PubMedPubMedCentralCrossRef

41.

Zhang X, Zhang W, Yuan X et al (2016) Neutrophils in cancer development and progression: roles, mechanisms, and implications (review). Int J Oncol 49:857–867. https://doi.org/10.3892/ijo.2016.3616PubMedCrossRef

42.

Oberg H-H, Wesch D, Kalyan S, Kabelitz D (2019) Regulatory ınteractions between neutrophils, tumor cells and T cells. Front Immunol 10:1690. https://doi.org/10.3389/fimmu.2019.01690PubMedPubMedCentralCrossRef

Title: Does systemic inflammation play a role in patients with pterygium?
Authors: Deniz Kilic
Soner Guven
Publication date: 01-09-2020
Publisher: Springer Netherlands
Published in: International Ophthalmology / Issue 9/2020
Print ISSN: 0165-5701
Electronic ISSN: 1573-2630
DOI: https://doi.org/10.1007/s10792-020-01414-4

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Does systemic inflammation play a role in patients with pterygium?

Abstract

Purpose

Methods

Results

Conclusion

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 9/2020

Changes in corneal thickness, upper and lower tear film in seasonal allergic conjunctivitis by steroid treatment: anterior segment optical coherence tomography study

Evaluation of emulsified silicone oil with spectral domain-optical coherence tomography and fluorescein angiography

Laser in situ keratomileusis (LASİK) in patients with superior steepening on corneal topography: Is it safe and predictable?

Excimer laser treatment combined with riboflavin ultraviolet-A (UVA) collagen crosslinking (CXL) in keratoconus: a literature review

Inner retinal toxicity due to silicone oil: a case series and review of the literature

Ciliary muscle dimensions measured by swept-source optical coherence tomography in eyes with primary open-angle glaucoma and healthy eyes